Therapies from fucoidan: An update

JH Fitton, DN Stringer, SS Karpiniec - Marine drugs, 2015 - mdpi.com
Fucoidans are a class of sulfated fucose-rich polysaccharides found in brown marine algae
and echinoderms. Fucoidans have an attractive array of bioactivities and potential …

Cancer stem cell markers in common cancers–therapeutic implications

T Klonisch, E Wiechec, S Hombach-Klonisch… - Trends in molecular …, 2008 - cell.com
Rapid advances in the cancer stem cell (CSC) field have provided cause for optimism for the
development of more reliable cancer therapies in the future. Strategies aimed at efficient …

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

PC Hermann, SL Huber, T Herrler, A Aicher, JW Ellwart… - Cell stem cell, 2007 - cell.com
Pancreatic adenocarcinoma is currently the fourth leading cause for cancer-related mortality.
Stem cells have been implicated in pancreatic tumor growth, but the specific role of these …

Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA/siRNA nanotherapy

Y Xie, Y Hang, Y Wang, R Sleightholm, DR Prajapati… - ACS …, 2020 - ACS Publications
Nanomedicines achieve tumor-targeted delivery mainly through enhanced permeability and
retention (EPR) effect following intravenous (IV) administration. Unfortunately, the EPR effect …

A next-generation dual-recombinase system for time-and host-specific targeting of pancreatic cancer

N Schönhuber, B Seidler, K Schuck, C Veltkamp… - Nature medicine, 2014 - nature.com
Genetically engineered mouse models (GEMMs) have dramatically improved our
understanding of tumor evolution and therapeutic resistance. However, sequential genetic …

E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex

J Von Burstin, S Eser, MC Paul, B Seidler, M Brandl… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Early metastasis is a hallmark of pancreatic ductal
adenocarcinoma and responsible for> 90% of pancreatic cancer death. Because little is …

[HTML][HTML] Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

D Zagzag, Y Lukyanov, L Lan, MA Ali, M Esencay… - Laboratory …, 2006 - Elsevier
Hypoxia and hypoxia-inducible factor-1 (HIF-1) play a critical role in glioblastoma multiforme
(GBMs). CXCR4 is involved in angiogenesis and is upregulated by HIF-1α. CXCR4 is a …

CXC chemokines in cancer angiogenesis and metastases

EC Keeley, B Mehrad, RM Strieter - Advances in cancer research, 2010 - Elsevier
The tumor microenvironment is extremely complex that depends on tumor cell interaction
with the responding host cells. Angiogenesis, or new blood vessel growth from preexisting …

Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy

RL Sleightholm, BK Neilsen, J Li, MM Steele… - Pharmacology & …, 2017 - Elsevier
Chemokine networks regulate a variety of cellular, physiological, and immune processes.
These normal functions can become appropriated by cancer cells to facilitate a more …

CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

S Singh, SK Srivastava, A Bhardwaj, LB Owen… - British journal of …, 2010 - nature.com
Background: Pancreatic cancer cells are highly resistant to drug therapy; however,
underlying causes remain largely unknown. We hypothesised that the activation of CXCL12 …